v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:        
Net income (loss) $ (17,315) $ 4,711 $ (640) $ (37,713)
Adjustments to reconcile net income (loss) to cash flows used in operations        
Depreciation 44 54 101 122
Amortization of right-of-use assets 265 653
Amortization of acquired intangible assets 209 209 418 418
Change in fair value of investment, related party 4,424 (1,747)
Change in fair value of contingent consideration (100) (1,900) (3,800) (1,402)
Change in fair value of warrant liabilities (1,403) (14,082) (19,017) 12,801
Warrant inducement expense     2,629
Stock-based compensation 610 1,068 1,852 129
Provision for inventory obsolescence 100 100 33
Provision for doubtful accounts 64 133 106 44
Non-cash interest expense 190 179 358 358
Changes in operating assets and liabilities:        
Accounts receivable 1,491 1,650 (70) (612)
Other receivables, related party 2,397 5,602 4,990 (11,387)
Prepaid expenses and other assets (302) 3,698 4,154 (3,809)
Inventories (7,617) (4,449) (2,810) 2,592
Accounts payable and related party payables 3,380 1,280 912 (773)
Operating lease liabilities (255) (781)
Accrued expenses and other liabilities (107) (240) (3,607) 12,484
Cash flows used in operating activities (14,025) (1,987) (16,199) (26,715)
Cash flows from investing activities        
Sales of equity investment, related party 178    
Purchases of investment, related party     (5,118)
Purchases of property and equipment (14) (36) (38) (11)
Cash flows provided by (used) in investing activities 164 (36) (5,156) (11)
Cash flows from financing activities        
Proceeds from issuance of common stock and warrants upon initial public offering, net of issuance costs     14,943
Proceeds from line of credit 5,700    
Proceeds from issuance of common stock and warrants in private placement, net of issuance costs 9,391 9,391 14,995
Proceeds from exercise of warrants     4,630 13,253
Repayment of line of credit (4,594)  
Cash flows provided by financing activities 1,106 9,391 14,021 43,191
Net increase (decrease) in cash and cash equivalents (12,755) 7,368 (7,334) 16,465
Cash, cash equivalents and restricted cash, at the beginning of the period 17,408 24,742 24,742 8,277
Cash, cash equivalents and restricted cash, at the end of the period 4,653 32,110 17,408 24,742
Supplemental disclosure of cash flow information        
Interest paid 4 1 2
Income taxes paid, net $ 30 32 56
Supplemental non-cash investing and financing activities        
Conversion of warrant liability to equity in connection with exercise of warrants     6,840 12,208
Issuance of common shares in exchange for investment, related party     3,683
Addition of right-of-use assets in exchange for operating lease liabilities     234
Issuance costs included in accrued expenses and other liabilities     44
Non-cash purchase of fixed assets     $ 8